News

A series of digital tests, carried out via a smartphone app, could enhance the detection of disease progression in Huntington’s disease and improve the efficiency of clinical trials, finds research led by scientists at UCL and Roche.

The first ever treatment for the rare neurodegenerative disease Friedreich’s ataxia – for which UCL and UCLH led the UK trial – has been approved for use in the UK by the medicines’ regulator.

The UCL Queen Square Institute of Neurology has been gifted more than £5 million by the Reta Lila Weston Trust for Medical Research, in support of initiatives to prevent, diagnose and treat a range of neurodegenerative diseases using artificial intelligence (AI).

Researchers in the UCL Queen Square Institute of Neurology find that the hippocampus sends signals to the visual cortex to predict what we are about to see.

Every year the Dean recognises the top postgraduate students, in terms of academic performance, from across the Faculty.

Dr Edwin Jabbari (UCL Queen Square Institute of Neurology) has received the prestigious fellowship to support his research in movement disorders.